Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Effect of high-dose preoperative methylprednisolone on recovery after total hip arthroplasty: a randomized, double-blind, placebo-controlled trial

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Recommendations for the nomenclature of cognitive change associated with anaesthesia and surgery-2018

    Research output: Contribution to journalReviewResearchpeer-review

  2. Front of neck: continued discovery of this anatomy essential for airway management

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Does ethnicity and education influence preoperative disability and expectations in patients undergoing total knee arthroplasty?

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Rehabilitation strategies for optimisation of functional recovery after major joint replacement

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Time-driven activity-based cost of outpatient total hip and knee arthroplasty in different set-ups

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Make it REAL: four simple points to increase clinical relevance in sport and exercise medicine research

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
BACKGROUND: /st>High-dose glucocorticoid may reduce postsurgical pain and improve recovery. We hypothesized that 125 mg methylprednisolone (MP) would reduce time to meet functional discharge criteria after total hip arthroplasty (THA). METHODS: /st>Forty-eight patients undergoing unilateral THA under spinal anaesthesia were consecutively included in this randomized, double-blind, placebo-controlled trial receiving preoperative i.v. MP or saline. All patients received a standardized, multimodal analgesic regime with paracetamol, celecoxib, and gabapentin. The primary outcome was time to meet well-defined functional discharge criteria. Secondary outcomes were handgrip strength and endurance, pain, nausea, vomiting, fatigue, sleep quality, and rescue analgesic-, antiemetic-, and hypnotic medicine requirements. The inflammatory response measured by C-reactive protein (CRP) and actual length of stay were also registered. Discharge criteria were assessed twice daily (at 09:00 and 14:00 h) until discharge. Other outcomes were assessed at 2, 4, 6, 8, and 24 h after operation, and also in a questionnaire from postoperative day (POD) 1-4. RESULTS: /st>Time to meet discharge criteria was [median (IQR) (95% CI), MP vs placebo]: 23.5 (23.3-23.7) (17.8-43.8) vs 23.5 (23.0-23.8) (20.0-46.8) h, the mean difference (95% CI) being -1.3 (-4.7 to 2.2) h, P=0.65. Overall pain for the first 24 h after surgery was significantly reduced in the MP vs the placebo group (PMP 125 mg i.v. before surgery added to a multimodal oral analgesic regime did not reduce time to meet functional discharge criteria after THA, but improved analgesia for the first 24 h.
Original languageEnglish
JournalBritish Journal of Anaesthesia
Volume110
Issue number1
Pages (from-to)66-73
ISSN0007-0912
DOIs
StatePublished - 2013

ID: 36342972